Bcl-2 reduces mutant rates in a transgenic lacZ reporter gene in mouse pre-B lymphocytes

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 522, Issue 1-2, 2003, Pages 135-144

  Felix, Klaus ^a   Rolink, Antonius ^b   Melchers, Fritz ^b   Janz, Siegfried ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b BASEL INSTITUTE FOR IMMUNOLOGY   (Switzerland)

Author keywords

In vivo mutagenesis assay; Ionizing radiation; pUR288; Shuttle vector

Indexed keywords

IMMUNOGLOBULIN M; PROTEIN BCL 2;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CELL DIFFERENTIATION; CELL MATURATION; CONTROLLED STUDY; DOSE RESPONSE; GAMMA IRRADIATION; GENE MUTATION; GENOTOXICITY; IN VITRO STUDY; LACZ REPORTER GENE; LIVER; MOUSE; MUTAGENESIS; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; REPORTER GENE; STEM CELL; TRANSGENIC ANIMAL;

ANIMALS; B-LYMPHOCYTES; CELL DIFFERENTIATION; FETUS; GAMMA RAYS; GENES, REPORTER; GENETIC VECTORS; LAC OPERON; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED DBA; MUTAGENESIS; PROTO-ONCOGENE PROTEINS C-BCL-2; RADIATION, IONIZING; RETROVIRIDAE; TRANSFECTION;

UNIDENTIFIED SHUTTLE VECTOR;

EID: 0037469393     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(02)00309-3     Document Type: Article

References (41)

1. Rajewsky K. Clonal selection and learning in the antibody system. Nature. 381:1996;751-778.
2. Hayakawa K., Li Y.S., Wasserman R., Sauder S., Shinton S., Hardy R.R. B lymphocyte developmental lineages. Ann. N.Y. Acad. Sci. 815:1997;15-29.
3. Rolink A., ten Boekel E., Yamagami T., Ceredig R., Andersson J., Melchers F. B cell development in the mouse from early progenitors to mature B cells. Immunol. Lett. 68:1999;89-93.
4. Rolink A., Kudo A., Karasuyama H., Kikuchi Y., Melchers F. Long-term proliferating early pre B cell lines and clones with the potential to develop to surface Ig-positive. EMBO J. 10:1991;327-336.
5. Boerrigter M.E., Dolle M.E., Martus H.J., Gossen J.A., Vijg J. Plasmid-based transgenic mouse model for studying in vivo mutations. Nature. 377:1995;657-659.
6. K. Felix, L.D. Rockwood, S. Janz, Transgenic shuttle vector assays for determining genetic differences in oxidative B-cell mutagenesis in vivo, in: C.K. Sen, L. Packer (Eds.), Redox Cell Biology & Genetics, a Volume of Methods in Enzymology, Academic Press, San Diego, 2002, pp. 434-448.
7. Zhang S., Ramsay E.S., Mock B.A. Cdkn2a the cyclin-dependent kinase inhibitor encoding p16INK4a and p19ARF, is a candidate for the plasmacytoma susceptibility locus, Pctr1. Proc. Natl. Acad. Sci. U.S.A. 95:1998;2429-2434.
8. Gossen J.A., de Leeuw W.J., Vijg J. LacZ transgenic mouse models: their application in genetic toxicology. Mutat. Res. 307:1994;451-459.
9. J. Vijg, G.R. Douglas, Bacteriophage lambda and plasmid lacZ transgenic mice for studying mutations in vivo, in: G.P. Pfeiffer (Ed.), Technologies for Detection of DNA Damage and Mutations, Plenum Press, New York, 1996, pp. 391-410.
10. Vijg J., Dolle M.E., Martus H.J., Boerrigter M.E. Transgenic mouse models for studying mutations in vivo: applications in aging research. Mech. Ageing Dev. 99:1997;257-271.
11. Boerrigter M.E. High sensitivity for color mutants in lacZ plasmid-based transgenic mice, as detected by positive selection. Environ. Mol. Mutagen. 32:1998;148-154.
12. Dolle M.E., Martus H.J., Novak M., van Orsouw N.J., Vijg J. Characterization of color mutants in lacZ plasmid-based transgenic mice, as detected by positive selection. Mutagenesis. 14:1999;287-293.
13. Boerrigter M.E., Vijg J. Sources of variability in mutant frequency determinations in different organs of lacZ plasmid-based transgenic mice: experimental features and statistical analysis. Environ. Mol. Mutagen. 29:1997;221-229.
14. Martus H.J., Dolle M.E., Gossen J.A., Boerrigter M.E., Vijg J. Use of transgenic mouse models for studying somatic mutations in aging. Mutat. Res. 338:1995;203-213.
15. Dolle M.E., Giese H., Hopkins C.L., Martus H.J., Hausdorff J.M., Vijg J. Rapid accumulation of genome rearrangements in liver but not in brain of old mice. Nat. Genet. 17:1997;431-434.
16. de Vries A., Dolle M.E., Broekhof J.L., Muller J.J., Kroese E.D., van Kreijl C.F., Capel P.J., Vijg J., van Steeg H. Induction of DNA adducts and mutations in spleen. Carcinogenesis. 18:1997;2327-2332.
17. Bielas J.H., Heddle J.A. From the cover: proliferation is necessary for both repair and mutation in transgenic mouse cells. Proc. Natl. Acad. Sci. U.S.A. 97:2001;11391-11396. (MEDLINE).
18. Brielmeier M., Bechet J.M., Falk M.H., Pawlita M., Polack A., Bornkamm G.W. Improving stable transfection efficiency: antioxidants dramatically improve the outgrowth of clones under dominant marker selection. Nucleic Acids Res. 26:1998;2082-2085.
19. Nohmi T., Katoh M., Suzuki H., Matsui M., Yamada M., Watanabe M., Suzuki M., Horiya N., Ueda O., Shibuya T., Ikeda H., Sofuni T. A new transgenic mouse mutagenesis test system using Spi- and 6-thioguanine selections. Environ. Mol. Mutagen. 28:1996;465-470.
20. Burkhart J.G., Malling H.V. Mutagenesis and transgenic systems: perspective from the mutagen, N-ethyl-N-nitrosourea. Environ. Mol. Mutagen. 22:1993;1-6.
21. Leach E.G., Narayanan L., Havre P.A., Gunther E.J., Yeasky T.M., Glazer P.M. Tissue specificity of spontaneous point mutations in lambda supF transgenic mice. Environ. Mol. Mutagen. 28:1996;459-464.
22. Gondo Y., Shioyama Y., Nakao K., Katsuki M. A novel positive detection system of in vivo mutations in rpsL (strA) transgenic mice. Mutat. Res. 360:1996;1-14.
23. Gossen J.A., de Leeuw W.J., Tan C.H., Zwarthoff E.C., Berends F., Lohman P.H., Knook D.L., Vijg J. Efficient rescue of integrated shuttle vectors from transgenic mice: a model for studying mutations in vivo. Proc. Natl. Acad. Sci. U.S.A. 86:1989;7971-7975.
24. Dean S.W., Myhr B. Measurement of gene mutation in vivo using Muta Mouse and positive selection for lacZ-phage. Mutagenesis. 9:1994;183-185.
25. Kohler S.W., Provost G.S., Fieck A., Kretz P.L., Bullock W.O., Putman D.L., Sorge J.A., Short J.M. Analysis of spontaneous and induced mutations in transgenic mice using a lambda ZAP/lacI shuttle vector. Environ. Mol. Mutagen. 18:1991;316-321.
26. Jakubczak J.L., Merlino G., French J.E., Muller W.J., Paul B., Adhya S., Garges S. Analysis of genetic instability during mammary tumor progression using a novel selection-based assay for in vivo mutations in a bacteriophage lambda transgene target. Proc. Natl. Acad. Sci. U.S.A. 93:1996;9073-9078.
27. Gossen J.A., Martus H.J., Wei J.Y., Vijg J. Spontaneous and X-ray-induced deletion mutations in a LacZ plasmid-based transgenic mouse model. Mutat. Res. 331:1995;89-97.
28. Nakamura S., Ikehata H., Komura J., Hosoi Y., Inoue H., Gondo Y., Yamamoto K., Ichimasa Y., Ono T. Radiation-induced mutations in the spleen and brain of lacZ transgenic mice. Int. J. Radiat. Biol. 76:2000;431-440.
29. Boerrigter M.E. Treatment of lacZ plasmid-based transgenic mice with benzo[a]pyrene: measurement of DNA adduct levels, mutant frequencies, and mutant spectra. Environ. Mol. Mutagen. 34:1999;140-147.
30. Wijnhoven S.W., Kool H.J., van Oostrom C.T., Beems R.B., Mullenders L.H., van Zeeland A.A., van der Horst G.T., Vrieling H., van Steeg H. The relationship between benzo[a]pyrene-induced mutagenesis and carcinogenesis in repair-deficient Cockayne syndrome group B mice. Cancer Res. 60:2001;5681-5687. (MEDLINE).
31. van Oostrom C.T., Boeve M., van Den Berg J., de Vries A., Dolle M.E., Beems R.B., van Kreijl C.F., Vijg J., van Steeg H. Effect of heterozygous loss of p53 on benzo[a]pyrene-induced mutations and tumors in DNA repair-deficient XPA mice. Environ. Mol. Mutagen. 34:1999;124-130.
32. Bruce-Keller A.J., Begley J.G., Fu W., Butterfield D.A., Bredesen D.E., Hutchins J.B., Hensley K., Mattson M.P. Bcl-2 protects isolated plasma and mitochondrial membranes against lipid peroxidation induced by hydrogen peroxide and amyloid beta-peptide. J. Neurochem. 70:1998;31-39.
33. Kane D.J., Sarafian T.A., Anton R., Hahn H., Gralla E.B., Valentine J.S., Ord T., Bredesen D.E. Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. Science. 262:1993;1274-1277.
34. Rimpler M.M., Rauen U., Schmidt T., Moroy T., de Groot H. Protection against hydrogen peroxide cytotoxicity in rat-1 fibroblasts provided by the oncoprotein Bcl-2: maintenance of calcium homoeostasis is secondary to the effect of Bcl-2 on cellular glutathione. Biochem. J. 340:1999;291-297.
35. Merad-Saidoune M., Boitier E., Nicole A., Marsac C., Martinou J.C., Sola B., Sinet P.M., Ceballos-Picot I. Overproduction of Cu/Zn-superoxide dismutase or Bcl-2 prevents the brain mitochondrial respiratory dysfunction induced by glutathione depletion. Exp. Neurol. 158:1999;428-436.
36. Deng G., Su J.H., Ivins K.J., Van Houten B., Cotman C.W. Bcl-2 facilitates recovery from DNA damage after oxidative stress. Exp. Neurol. 159:1999;309-318.
37. Hashimoto H., Chatterjee S., Berger N.A. Inhibition of etoposide (VP-16)-induced DNA recombination and mutant frequency by Bcl-2 protein overexpression. Cancer Res. 55:1995;4029-4035.
38. Voehringer D.W., McConkey D.J., McDonnell T.J., Brisbay S., Meyn R.E. Bcl-2 expression causes redistribution of glutathione to the nucleus. Proc. Natl. Acad. Sci. U.S.A. 95:1998;2956-2960.
39. Mirkovic N., Voehringer D.W., Story M.D., McConkey D.J., McDonnell T.J., Meyn R.E. Resistance to radiation-induced apoptosis in Bcl-2-expressing cells is reversed by depleting cellular thiols. Oncogene. 15:1997;1461-1470.
40. Voehringer D.W. BCL-2 and glutathione: alterations in cellular redox state that regulate apoptosis sensitivity. Free. Radic. Biol. Med. 27:1999;945-950.
41. Lopez-Hoyos M., Carrio R., Merino J., Merino R. Regulation of B cell apoptosis by Bcl-2 and Bcl-XL and its role in the development of autoimmune diseases. Int. J. Mol. Med. 1:1998;475-483.